Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of EUR 90.75 billion. The enterprise value is 107.59 billion.

Market Cap	90.75B
Enterprise Value	107.59B

Important Dates

The next confirmed earnings date is Wednesday, June 3, 2026.

Earnings Date	Jun 3, 2026
Ex-Dividend Date	Mar 27, 2026

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	-0.83%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	86.85%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 23.13 and the forward PE ratio is 14.15.

PE Ratio	23.13
Forward PE	14.15
PS Ratio	3.01
PB Ratio	2.17
P/TBV Ratio	n/a
P/FCF Ratio	19.72
P/OCF Ratio	14.65
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.96, with an EV/FCF ratio of 23.38.

EV / Earnings	27.42
EV / Sales	3.56
EV / EBITDA	12.96
EV / EBIT	19.04
EV / FCF	23.38

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.57.

Current Ratio	2.54
Quick Ratio	1.55
Debt / Equity	0.57
Debt / EBITDA	2.88
Debt / FCF	5.19
Interest Coverage	9.30

Financial Efficiency

Return on equity (ROE) is 9.39% and return on invested capital (ROIC) is 7.98%.

Return on Equity (ROE)	9.39%
Return on Assets (ROA)	4.57%
Return on Invested Capital (ROIC)	7.98%
Return on Capital Employed (ROCE)	8.09%
Weighted Average Cost of Capital (WACC)	7.13%
Revenue Per Employee	317,675
Profits Per Employee	41,298
Employee Count	95,000
Asset Turnover	0.39
Inventory Turnover	2.07

Taxes

In the past 12 months, Medtronic has paid 785.01 million in taxes.

Income Tax	785.01M
Effective Tax Rate	16.59%

Stock Price Statistics

The stock price has decreased by -3.08% in the last 52 weeks. The beta is 0.76, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-3.08%
50-Day Moving Average	76.95
200-Day Moving Average	80.86
Relative Strength Index (RSI)	31.70
Average Volume (20 Days)	1,115

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.80

Income Statement

In the last 12 months, Medtronic had revenue of EUR 30.18 billion and earned 3.92 billion in profits. Earnings per share was 3.04.

Revenue	30.18B
Gross Profit	19.66B
Operating Income	5.64B
Pretax Income	4.73B
Net Income	3.92B
EBITDA	8.03B
EBIT	5.64B
Earnings Per Share (EPS)	3.04

Balance Sheet

The company has 7.13 billion in cash and 23.87 billion in debt, giving a net cash position of -16.62 billion.

Cash & Cash Equivalents	7.13B
Total Debt	23.87B
Net Cash	-16.62B
Net Cash Per Share	n/a
Equity (Book Value)	41.84B
Book Value Per Share	32.46
Working Capital	12.40B

Cash Flow

In the last 12 months, operating cash flow was 6.20 billion and capital expenditures -1.59 billion, giving a free cash flow of 4.60 billion.

Operating Cash Flow	6.20B
Capital Expenditures	-1.59B
Depreciation & Amortization	2.40B
Net Borrowing	-862.24M
Free Cash Flow	4.60B
FCF Per Share	n/a

Margins

Gross margin is 65.16%, with operating and profit margins of 18.68% and 13.00%.

Gross Margin	65.16%
Operating Margin	18.68%
Pretax Margin	15.67%
Profit Margin	13.00%
EBITDA Margin	26.60%
EBIT Margin	18.68%
FCF Margin	15.25%

Dividends & Yields

This stock pays an annual dividend of 2.43, which amounts to a dividend yield of 3.43%.

Dividend Per Share	2.43
Dividend Yield	3.43%
Dividend Growth (YoY)	-6.44%
Years of Dividend Growth	n/a
Payout Ratio	78.65%
Buyback Yield	0.83%
Shareholder Yield	4.26%
Earnings Yield	4.32%
FCF Yield	5.07%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.98
Piotroski F-Score	6